ARTELO BIOSCIENCES, INC. (ARTL)
Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.
Address
505 LOMAS SANTA FE, SUITE 160
SOLANA BEACH, CA 92075
Founded
2011
Number of Employees
6
Website
http://www.artelobio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)